Compare BridgeBio Pharma Inc (BBIO) vs Innodata Inc (INOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Innodata Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Innodata Inc trades at $63.1 (market cap $2.05B). The key difference: BridgeBio Pharma Inc is far larger — about 8× Innodata Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | INOD | |
|---|---|---|
Market Cap | $16.36B | $2.05B |
Sector | Health | Technology |
52-Week High | $90.17 | $121.50 |
52-Week Low | $47.29 | $34.45 |
Enterprise Value | $18.14B | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →
